期刊文献+

Changes of serum CRP, serum uric acid and immunoglobulin in patients with renal damage of systemic lupus erythematosus 被引量:1

下载PDF
导出
摘要 Objective: To observe the expression level of serum CRP, serum uric acid and immunoglobulin (IgG, IgA and IgM) in patients with renal damage of systemic lupus erythematosus, and explore their clinical application value. Methods: A total of 95 patients with SLE were divided into lupus nephritis group (LN group, n = 64) and non-lupus nephritis group (NLN group n=31) according to the diagnostic criteria of lupus nephritis, and another 35 healthy subjects were selected as normal control group. Blood samples were collected from all subjects before treatment. Serum CRP and serum uric acid concentrations were measured by ELISA. The levels of serum immunoglobulins were detected by immunoturbidimetry in the same time. Finally, the results were analyzed statistically. Results: The levels of serum CRP and serum uric acid in patients with SLE were significantly higher than those in control group. The levels of serum CRP and serum uric acid in LN group of SLE patients were significantly higher than those in NLN group and control group. Serum CRP level in NLN group was significantly higher than that in control group. Serum uric acid level in NLN group was slightly higher than that of the control group, but the difference was not statistically significant. The level of serum immunoglobulin in SLE patients was higher than that in control group. The levels of serum immunoglobulin IgG, IgA and IgM in LN group of SLE patients were significantly higher than those in NLN group and control group. The levels of serum immunoglobulin IgG, IgA and IgM in NLN group of SLE patients were all higher than those in control group. Conclusion: Humoral immune of SLE patients with renal injury was activated at different degree, B-cell hyperthyroidism, severe systemic inflammatory response and kidney damage at varying degrees. Serum CRP, serum uric acid and immunoglobulin (IgG, IgA and IgM) may be involved in SLE renal injury pathological process, which is the early diagnosis of reference indicators.
作者 Jun Long
出处 《Journal of Hainan Medical University》 2017年第16期53-56,共4页 海南医学院学报(英文版)
  • 相关文献

参考文献1

二级参考文献17

  • 1段虹舫.免疫学指标联合检测诊断系统性红斑狼疮的价值研究[J].实用心脑肺血管病杂志,2013,21(8):108-109.
  • 2Robinson ES,Werth VP.The role of cytokines in the pathogenesis of cutaneous lupus erythematosus[J].Cytokine,2015,73(2):326-334.
  • 3Hafez SS,Saad Wel S,Shedid NH.B-cell-attracting chemokine-1(BCA-1/CXCL13)in systemic lupus erythematosus,its correlation to disease activity and renal involvement[J].Egypt J Immunol,2014,21(2):23-32.
  • 4Marie MA,Abu Khalil RE,Habib HM.Urinary CXCL10:a marker of nephritis in lupus patients[J].Reumatismo,2014,65(6):292-297.
  • 5Elia G.Interferon-γ-Inducible chemokines in Systemic Lupus Erythematosus[J].ClinTer,2015,166(1):41-46.
  • 6Ichinose K,Arima K,Ushigusa T,et al.Distinguishing the cerebrospinal fluid cytokine profile in neuropsychiatric systemic lupus erythematosus from other autoimmune neurological diseases[J].ClinImmunol,2015,157(2):114-120.
  • 7Antonelli A,Ferrari SM,Giuggioli D,et al.Chemokine(C-X-C motif)ligand(CXCL)10in autoimmune diseases[J].Autoimmun Rev,2014,13(3):272-280.
  • 8Schiffer L,Worthmann K,Haller H,et al.CXCL13as a new biomarker of systemic lupus erythematosus and lupus nephritisfrom bench to bedside?[J].ClinExpImmunol,2015,179(1):85-89.
  • 9Worthmann K,Gueler F,von Vietinghoff S,et al.Pathogenetic role of glomerular CXCL13expression in lupus nephritis[J].ClinExpImmunol,2014,178(1):20-27.
  • 10Qin M,Guo Y,Jiang L,et al.Elevated levels of serum sCXCL16in systemic lupus erythematosus;potential involvement in cutaneous and renal manifestations[J].ClinRheumatol,2014,33(11):1595-601.

共引文献9

同被引文献9

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部